Nicholas Balch

Nicholas Balch is an experienced analyst specializing in equity research within the technology sector at Hedgeye Risk Management, LLC, since August 2019. Previously, Nicholas held the position of Internal Wholesaler at NAV Capital Group, LLC, where responsibilities included developing marketing strategies and coordinating client meetings. Prior roles also include research assistant positions at Strong Hospital, focusing on integrated photonics sensors, and Johns Hopkins Hospital, where Nicholas contributed to research on biomarkers in pancreatic cancer. Nicholas earned a degree in Biology from the University of Rochester in 2019.